- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 159813, 6 pages
VEGF and bFGF Gene Polymorphisms in Patients with Non-Hodgkin's Lymphoma
1Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, L. Pasteura 4, 50-367 Wroclaw, Poland
2Department of Internal, Occupational Diseases and Hypertension, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland
3Laboratory of Clinical Immunogenetics and Pharmacogenetics, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland
Received 14 April 2013; Revised 26 June 2013; Accepted 3 July 2013
Academic Editor: Konstantinos Papatheodorou
Copyright © 2013 Tomasz Wróbel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [6 citations]
The following is the list of published articles that have cited the current article.
- Carol Lozano-Santos, Jimena Martinez-Velasquez, Belen Fernandez-Cuevas, Natividad Polo, Belen Navarro, Isabel Millan, Jose Miguel Garcia, Rosa Collado, Pedro Sanchez-Godoy, Felix Carbonell, Jose Antonio Garcia-Vela, Jose Antonio Garcia-Marco, and Natalia Gomez-Lozano, “Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia,” Plos One, vol. 9, no. 6, 2014.
- Heba Mahmoud Gouda, Mervat Mamdooh Khorshied, Maha Hamdi Sissy, Iman Abdel Mohsen Shaheen, and Mohsen Mokhtar Abdel Mohsen, “Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin’s lymphoma in Egyptians,” Annals of Hematology, 2014.
- Hala Aly Abdel Rahman, Mervat Mamdooh Khorshied, Ola M. Reda Khorshid, and Shirihan Mahmoud Mahgoub, “Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt,” Annals of Hematology, vol. 93, no. 11, pp. 1859–1865, 2014.
- Omer Nuri Pamuk, Gulsum Emel Pamuk, Hilmi Tozkir, Mehmet Sevki Uyanik, Hakan Gurkan, and Julide Duymaz, “Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course,” Leukemia & Lymphoma, pp. 1–6, 2015.
- Mihai Dumitru Porojan, Andreea Catana, Radu A. Popp, Dan L. Dumitrascu, and Cornelia Bala, “The role of NOS2A-954G/C and vascular endothelial growth factor+936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinop,” Therapeutics And Clinical Risk Management, vol. 11, pp. 1743–1748, 2015.
- Tadeusz Osadnik, Joanna Katarzyna Strzelczyk, Rafal Regula, Kamil Bujak, Martyna Fronczek, Malgorzata Gonera, Marcin Gawlita, Jaroslaw Wasilewski, Andrzej Lekston, Anna Kurek, Marek Gierlotka, Przemyslaw Trzeciak, Michal Hawranek, Zofia Ostrowska, Andrzej Wiczkowski, Lech Polonski, and Mariusz Gasior, “The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-beta 1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Pat,” Plos One, vol. 11, no. 3, 2016.